Trial intelligence / Profile preview

Remifentanil + Propofol versus Remifentanil + Ketamine in Diagnostic Bronchoscopy

IRCT20171202037716N1Phase 2Completed

Sponsor
Ardabil University of Medical Sciences
Start
Jan 2018
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in anxiety disorder comparing Remifentanil + Propofol with Remifentanil + Ketamine (2 arms). Started Jan 2018; status: completed.

02

Drugs

remifentanilpropofolketamine
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on IRCT20171202037716N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171202037716N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call